Johan Strömqvist
Direttore/Membro del Consiglio presso NEWBURY PHARMACEUTICALS AB
Profilo
Johan Strömqvist is the founder of Single Technologies AB, where he holds the titles of President & Director since 2014.
He is currently an Independent Director at Newbury Pharmaceuticals AB since 2020.
Dr. Strömqvist has a graduate degree from the University of Stockholm and graduate and doctorate degrees from the Royal Institute of Technology.
Posizioni attive di Johan Strömqvist
| Società | Posizione | Inizio |
|---|---|---|
| NEWBURY PHARMACEUTICALS AB | Direttore/Membro del Consiglio | 01/01/2020 |
Single Technologies AB
 Single Technologies AB Miscellaneous Commercial ServicesCommercial Services Single Technologies AB develops 3-D sequencing technology. The company is based in Stockholm, Sweden. The Swedish company was founded in 2014 by Johan Strömqvist, Annika Bolind Bågenholm, Bengt Sahlgren, Raoul Stubbe. | Fondatore | 01/01/2014 |
Formazione di Johan Strömqvist
| University of Stockholm | Graduate Degree |
| Royal Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NEWBURY PHARMACEUTICALS AB | Health Technology |
| Aziende private | 1 |
|---|---|
Single Technologies AB
Single Technologies AB Miscellaneous Commercial ServicesCommercial Services Single Technologies AB develops 3-D sequencing technology. The company is based in Stockholm, Sweden. The Swedish company was founded in 2014 by Johan Strömqvist, Annika Bolind Bågenholm, Bengt Sahlgren, Raoul Stubbe. | Commercial Services |
- Borsa valori
- Insiders
- Johan Strömqvist
